[Cardiovascular risk in patients with rheumatoid arthritis]
Insights
Standard cardiovascular risk factors underestimate risk in rheumatoid arthritis (RA) patients. New factors like inflammation, hemostasis, and arterial stiffness are crucial for accurate RA cardiovascular risk assessment.
Area of Science:
- Rheumatology
- Cardiology
- Vascular Biology
Context:
- Rheumatoid arthritis (RA) is associated with increased cardiovascular disease (CVD) risk.
- Standard cardiovascular risk factors may not fully capture this elevated risk in RA patients.
Purpose:
- To determine cardiovascular risk in rheumatoid arthritis (RA) patients using standard and novel risk factors.
- To investigate the role of inflammation, hemostasis, and arterial stiffness in RA-related CVD risk.
Summary:
- The study analyzed standard cardiovascular risk factors and novel markers in 312 RA patients and 57 controls.
- RA patients exhibited higher arterial hypertension and C-reactive protein levels. Significant alterations in hemostasis and increased arterial stiffness were observed.
- Standard risk scores (Framingham, SCORE) were lower than expected, highlighting limitations in assessing RA cardiovascular risk.
Impact:
- Standard cardiovascular risk assessment tools are insufficient for RA patients.
- Incorporating inflammation, hemostasis, and arterial stiffness is essential for accurate CVD risk stratification in RA.
- This research informs clinical practice for better cardiovascular risk management in RA.
Aim:
Cardiovascular risk determination in patients with rheumatoid arthritis (RA) on the basis of standard and new risk factors (RF).
Material And Methods:
Incidence of standard cardiovascular RF was studied in 312 RA patients and 57 healthy controls. Overall coronary risk (OCR) and cardiovascular death risk (SCORE scale), coronary heart disease risk (Framingem scale) were analysed. In addition, such RF as severity of systemic inflammation, some hemostatic indices, arterial wall stiffness were assessed.
Results:
Arterial hypertension (AH) occurred in 63.5% and hypercholesterinemia in 57.7% patients. AH in RA males is detected significantly more often than in population while blood lipid composition is satisfactory because of high HDLP cholesterol. The Framingem index in RA patients is lower than in the controls (7.7 +/- 5.4 and 9.4 +/- 9.3%), mean SCORE was 2.16 +/- 2.9% (17.3% patients had high SCORE), a high OCR was registered in 25.7%. High level of C-reactive protein, platelets (320 x 10(9)/l), hyperfibrinogenemia were found in 70.2, 31.1% and 55.9% patients, respectively. RA is accompanied with high activity of Willebrand factor, a low level of antithrombin III, suppression of fibrinolysis in blood plasm (p < 0.05). This reflects high thrombogenic blood potential, high risk of thrombosis and related complications of coronary heart disease. Aortic pulse wave velocity over 12 m/s was recorded significantly more frequently in RA than in control patients (p < 0.001), RA females had high arterial rigidity both in the periphery and aorta.
Conclusion:
Cardiovascular risk indices based on standard RF cannot assess the risk in RA patients. Additional factors should be taken into consideration: severity of inflammation, hemostasis, arterial stiffness.
Related Concept Videos
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction

